Ruud P.M. Dings

5.2k citations
74 papers · 3.7k indexed · h-index 35

Ruud P.M. Dings

74 papers receiving 3.6k citations

Peers

Ruud P.M. Dings
Comparison fields: 5 of 122
  • Immunology 1.3k
  • Cancer Research 698
  • Oncology 955
  • Molecular Biology 2.3k
  • Immunology and Allergy 173
Replace Galia Blum with:
Galia Blum Israel
Patrycja Nowak‐Sliwinska Switzerland
Gayathri R. Devi United States
Moorthy P. Ponnusamy United States
Heinz Läubli Switzerland
Steinar Aamdal Norway
Helmut Schaider Australia
Sandra Van Schaeybroeck United Kingdom
Mona Mostafa Mohamed Egypt
Hetty Timmer‐Bosscha Netherlands
Ruud P.M. Dings relative to Galia Blum Israel Galia Blum's profile →
Citations per field
00.5×3.7×
Galia Blum · 1×
Citations per year

Countries citing papers authored by Ruud P.M. Dings

Since Specialization
Citations

This map shows the geographic impact of Ruud P.M. Dings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruud P.M. Dings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruud P.M. Dings more than expected).

Fields of papers citing papers by Ruud P.M. Dings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruud P.M. Dings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruud P.M. Dings. The network helps show where Ruud P.M. Dings may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ruud P.M. Dings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ruud P.M. Dings Line = papers co-authored together Ruud P.M. Dings links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20231
3 20214
4 20213
5 20213
6 201927
7 201955
8 201819
9 201820
10 201826
11 201549
12 201514
13 20138
14 201237
15 201159
16 200729
17 2006129
18 200566
19 200447
20 200061

About Ruud P.M. Dings

Ruud P.M. Dings is a scholar working on Cancer Research, Toxicology and Immunology, having authored 74 papers that have together received 3.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (22 papers), Cancer, Hypoxia, and Metabolism (15 papers), Galectins and Cancer Biology (12 papers), Nanoplatforms for cancer theranostics (9 papers), Peptidase Inhibition and Analysis (7 papers), Glycosylation and Glycoproteins Research (6 papers), Immunotherapy and Immune Responses (6 papers) and Signaling Pathways in Disease (6 papers). The work is most often cited by research in Immunology (1.3k citations), Cancer Research (698 citations) and Oncology (955 citations). Ruud P.M. Dings has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Kevin H. Mayo, Arjan W. Griffioen, Robert J. Griffin, Victor L. Thijssen, Irina V. Nesmelova, Chang W. Song, Ricardo Brandwijk, Azemat Jamshidi‐Parsian, Samir V. Jenkins and Melissa Loren. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Accounts of Chemical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026